Target intelligence / Profile preview

Bla g 2 (German cockroach allergen Bla g 2) (Bla g 2)

Target
Bla g 2
Molecular classification
Allergen, Glycoprotein, Homolog of aspartic proteinase family (but enzymatically inactive)
01

Overview

Bla g 2 is a major glycoprotein allergen produced by the German cockroach (*Blattella germanica*) and is one of the most potent indoor allergens associated with asthma and other respiratory allergies. It has a molecular weight around 36 kDa and shows strong sequence homology with aspartic proteinases; however, it lacks enzymatic activity due to critical amino acid substitutions. Instead, its three-dimensional structure suggests potential peptide-binding properties. Found abundantly in digestive organs and feces of *B. germanica*, environmental exposure leads to high rates (60–80%) of specific IgE sensitization among allergic individuals. Recombinant forms are used both diagnostically (as biomarkers) and therapeutically (for desensitization). The main therapeutic challenge lies in balancing effective immune modulation while minimizing risk from potent IgE binding.

Other names
German cockroach allergen Bla g 2Cockroach allergen group 2Blattella germanica group 2 allergen
02

Mechanism of action

For immunotherapeutics targeting this molecule: - Induction of immune tolerance by repeated controlled exposure to recombinant or modified forms of the allergen, aiming to reduce IgE-mediated hypersensitivity responses and promote regulatory T cell responses

03

Biological functions

Induces IgE-mediated immune response in sensitized individualsMajor indoor environmental allergen contributing to allergic diseases such as asthmaThe precise biological function within the insect is unclear; it may have a peptide-binding role but lacks protease activity
04

Disease associations

Asthma (especially in urban environments)Allergic rhinitisOther IgE-mediated allergic diseases related to cockroach exposure
05

Safety considerations

Risk of inducing allergic reactions during immunotherapy due to high potency in stimulating IgE production.Therapeutic challenge includes designing hypoallergenic variants that retain T-cell reactivity but have reduced capacity for cross-linking patient IgE antibodies, thus minimizing risk of anaphylaxis during treatment
06

Interacting drugs

Allergen-specific immunotherapy using recombinant or purified Bla g 2 protein for desensitization purposes
07

Biomarkers

Serum specific IgE against Bla g 2 is used as a biomarker for diagnosing sensitization and monitoring efficacy during immunotherapy for cockroach allergy

Beyond the preview

Go deeper on Bla g 2 (German cockroach allergen Bla g 2) (Bla g 2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bla g 2 (German cockroach allergen Bla g 2) (Bla g 2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call